Clinical observation on the efficacy and safety of NaHao oral antibacterial nursing solution in relieving oral mucositis caused by tumor radiotherapy and chemotherapy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200064766

Enrollment

Unknown

Registered

2022-10-17

Start date

2021-09-10

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucositis associated with radiotherapy and chemotherapy

Interventions

single arm:NaHao oral antibacterial nursing solution treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Subjects voluntarily participate in the experiment and sign an informed consent form; 2. Age range from 18 to 75 years old, regardless of gender, with a Karzai score of 50 or above, able to independently describe symptoms and feelings; 3. Patients with oral ulcers of grade II or above during tumor treatment, or persistent mucosal pain with a score of>=4 points.

Exclusion criteria

Exclusion criteria: 1. Patients who previously indicated known allergy to any ingerdients in the NaHao; 2. Patients are unwilling to follow the research procedures and treatments, the researchers determine that they should not participate in the study; 3. Researchers believe that it is inappropriate to participate in this clinical trial for other reasons.

Design outcomes

Primary

Measure	Time frame
Karnofsky;Visual Analogue Score;WHO Oral toxicity scale;Numerical Rating Scales;	—

Countries

China

Contacts

Public ContactDan Yan

Jiangsu Cancer Hospital

sharon@njmu.edu.cn+86 17372279751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026